Enhancing Nateglinide Delivery Through Mucoadhesive Buccal Tablets: Formulation and Assessment
Pharmaceutical sciences- Pharmaceutics
DOI:
https://doi.org/10.22376/ijlpr.2023.13.6.P332-P343Keywords:
Buccal, Chitosan, Diabetes, Nateglinide, Sodium alginate, TabletsAbstract
Diabetes is a chronic illness that affects how the body converts food into energy. Numerous organs may be harmed asa result of poor diabetes control. The primary goal of the research project is to prepare and assess mucoadhesive buccal tabletsof nateglinide for type 2 diabetes treatment, employing HPMC K100, Chitosan, and sodium alginate as mucoadhesive polymersalone and in a mixture through direct compression. The assessment parameters include thickness, hardness, weight variation,friability, drug content, swelling index, surface pH, in-vitro drug release, and ex-vivo mucoadhesive strength. FTIR analysis indicatedno drug-excipient interaction. Physical parameters (thickness, hardness, weight variation, friability) adhered to pharmacopoeiastandards, while drug content ranged from 83.65 to 99.76%. The swelling index varied from 100±7.64 to 147.5±2.89%. FormulationF5 (Sodium alginate) exhibited the highest drug discharge (92.1±2.37%), while F8 (HPMC K100 and Sodium alginate) demonstratedsustained discharge (79.1±2.13% at 8 h) and the highest mucoadhesive strength (33.0±2.00 g). Discharge kinetics followed zeroorder (F1, F3, F4, F7, and F9) and Korsemeyer Peppas models (F2, F5, and F6). The study concludes that the potential of theseformulations for controlled drug discharge and oral mucosal adhesion in diabetes management.Keywords: , , , , ,
References
Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021;171(2):179-89. doi: 10.1007/s10517-021-05191-7, PMID 34173093.
Shravani Y, Ahad HA, Haranath C, gari Poojitha B, Rahamathulla S, Rupasree A. Past decade work done on cubosomes using factorial design: A fast track information for researchers. Int J Life Sci Pharm Res. 2021;11(1):124-35.
Jwalapuram R, Ahad HA, Haranath C, Thadipatri R, Varshitha C, Kumar YB. A desktop reference to the solubility enhancement of drugs with the aid of surfactants. Int J Life Sci Pharm Res. 2020;11(5):11-6.
SantaCruz-Calvo S, Bharath L, Pugh G, SantaCruz-Calvo L, Lenin RR, Lutshumba J, et al. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat Rev Endocrinol. 2022;18(1):23-42. doi: 10.1038/s41574-021-00575-1, PMID 34703027.
Ahad HA, Haranath C, Kondaveeti S, Konjeti S, Gangireddy S, Ibrahim O. Herbs in dentifrices for dental care and hygiene: a comprehensive Review. Res J Pharm Technol. 2020;13(10):5052-4. doi: 10.5958/0974-360X.2020.00885.9.
Hahr AJ, Molitch ME. Management of diabetes mellitus in patients with CKD: core curriculum 2022. Am J Kidney Dis. 2022;79(5):728-36. doi: 10.1053/j.ajkd.2021.05.023, PMID 34600745.
Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001;15(1):137-42. doi: 10.1046/j.1365-2036.2001.00896.x, PMID 11136287.
Weaver ML, Orwig BA, Rodriguez LC, Graham ED, Chin JA, Shapiro MJ, et al. Pharmacokinetics and metabolism of nateglinide in humans. Drug Metab Dispos. 2001;29(4 Pt 1):415-21. PMID 11259325.
Shah P, Rahman SA, Demirbilek H, Güemes M, Hussain K. Hyperinsulinaemic hypoglycaemia in children and adults. Lancet Diabetes Endocrinol. 2017;5(9):729-42. doi: 10.1016/S2213-8587(16)30323-0, PMID 27915035.
Razzaq S, Syed MA, Irfan M, Khan I, Sarfraz RM, Shakir R, et al. Optimization of metronidazole SR buccal tablet for gingivitis using genetic algorithm. Pak J Pharm Sci. 2021;34(6):2149-58. PMID 35034875.
Koirala S, Nepal P, Ghimire G, Basnet R, Rawat I, Dahal A, et al. Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac. Heliyon. 2021;7(3):e06439. doi: 10.1016/j.heliyon.2021.e06439, PMID 33786387.
Veseli A, Žakelj S, Kristl A. A Review of methods for solubility determination in biopharmaceutical drug characterization. Drug Dev Ind Pharm. 2019;45(11):1717-24. doi: 10.1080/03639045.2019.1665062, PMID 31512934.
Noya EG, Vega C, de Miguel E. Determination of the melting point of hard spheres from direct coexistence simulation methods. J Chem Phys. 2008;128(15):154507. doi: 10.1063/1.2901172, PMID 18433235.
Jain S, Bhandari A, Purohit S. Spectrophotometric determination of nateglinide in bulk and tablet dosage forms. Asian J Pharm. 2009;3(3). doi: 10.4103/0973-8398.56301.
Venkatesh S, Jyothi S, Chiluka R, Padmavathi Y. Development of uv-spectrophotometric method for the simultaneous estimation of nateglinide and piperine in combined tablet dosage form. Asian J Pharm Anal. 2020;10(3):134-40. doi: 10.5958/2231-5675.2020.00024.1.
Puviarasan N, Arjunan V, Mohan S. FT-IR and FT-Raman studies on 3-aminophthalhydrazide and N-aminophthalimide. Turk J Chem. 2002;26(3):323-34.
Shah RB, Tawakkul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech. 2008;9(1):250-8. doi: 10.1208/s12249-008-9046-8, PMID 18446489.
Sogias IA, Williams AC, Khutoryanskiy VV. Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen. Int J Pharm. 2012;436(1-2):602-10. doi: 10.1016/j.ijpharm.2012.07.007, PMID 22842627.
Ahad HA, Chinthaginjala H, Priyanka MS, Raghav DR, Gowthami M, Jyothi VN. Datura stramonium Leaves mucilage aided buccoadhesive films of aceclofenac using 3² factorial design with design-expert software. Indian J Pharm Educ Res. 2021;55.
Ahad HA, Dasari RR, Haranath C, Gowthami M, Varam NJ, Sravanthi P. Bygone exertion on mucoadhesive bilayered tablets. Res J Pharm Technol. 2021;14(11):5991-2.
Sharma S, Thakur SL, Joshi SK, Kulkarni SS. Measurement of gingival thickness using digital vernier caliper and ultrasonographic method: a comparative study. J Investig Clin Dent. 2014;5(2):138-43. doi: 10.1111/jicd.12026, PMID 23355379. Sharma S, Thakur SL, Joshi SK, Kulkarni SS. Measurement of gingival thickness using digital vernier caliper and ultrasonographic method: a comparative study. J Investig Clin Dent. 2014;5(2):138-43. doi: 10.1111/jicd.12026, PMID 23355379.
Mulhall JP, Goldstein I, Bushmakin A, Cappelleri J, Hvidsten K. Validation of the erection hardness score. The 15th Anniversary of the First Oral Therapy for Erectile Dysfunction. 2014;11(2):123-4.
Osei-Yeboah F, Sun CC. Validation and applications of an expedited tablet friability method. Int J Pharm. 2015;484(1-2):146-55. doi: 10.1016/j.ijpharm.2015.02.061, PMID 25724139.
Katori N, Aoyagi N, Kojima S. The study of the applicability of content uniformity and weight variation test—the state of commercial tablets and capsules in Japan. Chem Pharm Bull (Tokyo). 2001;49(11):1412-9. doi: 10.1248/cpb.49.1412, PMID 11724231.
Jena K, Das M, Das M, De A, Mitra D, Samanta A. Determination of efficacy of a natural tablet binder: characterization and in-vitro release study. Asian J Pharm Clin Res. 2014;7(3):184-68.
Ahad HA, Haranath C, Rahul Raghav D, Gowthami M, Naga Jyothi V, Sravanthi P. Overview on recent optimization techniques in gastro retentive microcapsules by factorial design. Int J Pharm Sci Res. 2019;10(9):247-54.
Mundarinti SHB, Ahad HA. Impact of Pistacia lentiscus Plant Gum on Particle Size and Swelling Index in Central Composite Designed amoxycillin trihydrate mucoadhesive Microspheres. Ind J Pharm Educ Res. 2023;57(3):763-72. doi: 10.5530/ijper.57.3.93.
Kadam PB, Dias RJ, Mali KK, Havaldar VD, Mahajan NS. Formulation and evaluation of buccoadhesive tablets of atenolol. J Pharm Res. 2008;1(2):193-9.
Babu GN, Muthukaruppan M, Ahad HA. Impact of Azadirachta indica Fruit Mucilage on particle size and swelling index in Central Composite Designed acyclovir mucoadhesive microspheres. Baghdad Sci J. 2023;20(2):0425-. doi: 10.21123/bsj.2022.6786.
Babu GN, Muthukarupan M, Ahad HA. Neem fruit mucilage impact on acyclovir release at different intervals: A central composite design screening. Int J Pharm Res Allied Sci. 2021;10(4):131-41. doi: 10.51847/Uh1ekmZM0d.
Singh S, Govind M, Bothara SB. A review on in vitro—in vivo mucoadhesive strength assessment. PhaTechMed. 2013;2:221-9.
Kavitha K, Kumar MR, Singh SJ. Novel mucoadhesive polymers-a Review. J Appl Pharm Sci. 2011(Issue):37-42.
Chinthaginjala H, Telkar MB, Hindustan AA, Bhupalam P. Formulation development and optimization of famotidine mucoadhesive tablets by central composite design. Indian J Pharm Educ Res. 2022;56(4):1044-51. doi: 10.5530/ijper.56.4.185.
Ahad HA, Chinthaginjala H, Meharajunnisa B, Vandana N, Gudisipalli R, Nikhila P. Past work done on the matrix tablets: A quick reference for the research beginner in sustained-release dosage forms. Int J Pharm Investigation. 2023;13(3):367-72. doi: 10.5530/ijpi.13.3.047.
Hossain MS, Jahan S, Al Rezwan Rahman SAR, Rahman M, Kumar D, Paul S, et al. Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities. Heliyon. 2023;9(3):e14259. doi: 10.1016/j.heliyon.2023.e14259, PMID 36938401.
Pandey N, Sah NA, Mahara K. Formulation and evaluation of floating microspheres of nateglinide. Int J Pharm Sci Res. 2016;7(11):453-64.
Bruni G, Berbenni V, Milanese C, Girella A, Cardini A, Viganò E et al. Thermodynamic relationships between nateglinide polymorphs. J Pharm Biomed Anal. 2009 Dec 5;50(5):764-70. doi: 10.1016/j.jpba.2009.06.017, PMID 19570642.
Kanakapura B, Penmatsa VK. A review of analytical methods for the determination of nateglinide in pharmaceuticals and biological samples. Pharm Chem J. 2016 Mar;49(12):854-67. doi: 10.1007/s11094-016-1386-1.
Patel KB, Vyas JR, Upadhyay UM. Formulation and evaluation of sustained release matrix tablets of nateglinide. J Drug Deliv Ther. 2015 Sep 21;5(5):19-25. doi: 10.22270/jddt.v5i5.1130.
Venkatesh DN, Meyyanathan SN, Shanmugam R, Zielinska A, Campos JR, Ferreira JD et al. Development, in vitro release and in vivo bioavailability of sustained release nateglinide tablets. J Drug Deliv Sci Technol. 2020 Feb 1;55:101355. doi: 10.1016/j.jddst.2019.101355.
Sharma PR, Lewis SA. Design and in vitro/in vivo evaluation of extended release matrix tablets of nateglinide. J Young Pharm. 2013 Dec 1;5(4):167-72. doi: 10.1016/j.jyp.2013.11.003, PMID 24563597.
Ryakala H, Dineshmohan S, Ramesh A, Gupta VR. Formulation and in vitro evaluation of bilayer tablets of nebivolol hydrochloride and nateglinide for the treatment of diabetes and hypertension. J Drug Deliv. 2015;2015:827859. doi: 10.1155/2015/827859, PMID 25648606.
Waidya KP, Sri SR, Janaki T. Formulation development and characterisation of repaglinide buccal tablets. Asian J Pharm Technol. 2019;9(2):79-88. doi: 10.5958/2231-5713.2019.00014.X.
Koirala S, Nepal P, Ghimire G, Basnet R, Rawat I, Dahal A et al. Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac. Heliyon. 2021 Mar 1;7(3):e06439. doi: 10.1016/j.heliyon.2021.e06439, PMID 33786387.
Palem CR, Gannu R, Yamsani SK, Yamsani VV, Yamsani MR. Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization. Drug Deliv. 2011 Jul 1;18(5):344-52. doi: 10.3109/10717544.2011.557786, PMID 21351826.
Boyapally H, Nukala RK, Bhujbal P, Douroumis D. Controlled release from directly compressible theophylline buccal tablets. Colloids Surf B Biointerfaces. 2010 Jun 1;77(2):227-33. doi: 10.1016/j.colsurfb.2010.01.031, PMID 20188529.
Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm. 2004 Jan 1;30(9):985-93. doi: 10.1081/DDC-200037245, PMID 15554223.
Alur HH, Pather SI, Mitra AK, Johnston TP. Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets. Pharm Dev Technol. 1999 Jan 1;4(3):347-58. doi: 10.1081/PDT-100101370, PMID 10434280.
Gowthamarajan K, Jawahar N, Wake P, Jain K, Sood S. Development of buccal tablets for curcumin using Anacardium occidentale gum. Carbohydr Polym. 2012 May 16;88(4):1177-83. doi: 10.1016/j.carbpol.2012.01.072.
Patel VM, Prajapati BG, Patel HV, Patel KM. Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS PharmSciTech. 2007 Sep;8(3):E77. doi: 10.1208/pt0803077, PMID 17915827.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Chrishmitha Sequeira, Sujatha P Muchalambe, Hindustan Abdul Ahad, Abhishek Jayanna, Pynskhemlin Syiemlieh, Shreya J Poojari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
